Try our Advanced Search for more refined results

May 13, 2022

Fate Therapeutics, Inc. et al v. Shoreline Biosciences, Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 17, 2023

    Stem Cell Research Biz Loses $7M Atty Fee Bid In Patent Fight

    A California federal judge has denied a stem cell research startup's bid for a $7 million attorney fee award after successfully defeating a rival's patent infringement suit, saying the dispute was a "run-of-the-mill patent case" that doesn't warrant awarding fees to the prevailing party.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login